Astrana Health, Inc.
General ticker "ASTH" information:
- Sector: Health Care
- Industry: Medical - Care Facilities
- Capitalization: $1.5B (TTM average)
Astrana Health, Inc. does not follow the US Stock Market performance with the rate: -10.2%.
Estimated limits based on current volatility of 3.5%: low 21.85$, high 23.43$
Factors to consider:
- Total employees count: 1900 as of 2024
- Price in estimated range
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [20.75$, 39.12$]
- 2025-12-31 to 2026-12-31 estimated range: [18.16$, 34.64$]
Financial Metrics affecting the ASTH estimates:
- Positive: with PPE of 37.5 at the end of fiscal year the price was neutral
- Positive: -5.04 < Operating profit margin, % of 4.39
- Positive: 42.77 < Shareholder equity ratio, % of 52.60 <= 64.37
- Negative: Investing cash flow per share per price, % of -12.08 <= -4.43
- Positive: 1.84 < Return on assets ratio (scaled to [-100,100]) of 3.55
- Positive: -9.11 < Industry operating profit margin (median), % of -2.81
- Positive: -0.04 < Industry operating cash flow per share per price (median), % of 3.20
Short-term ASTH quotes
Long-term ASTH plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $1,144.16MM | $1,386.66MM | $2,034.54MM |
| Operating Expenses | $1,039.90MM | $1,302.05MM | $1,945.19MM |
| Operating Income | $104.27MM | $84.61MM | $89.35MM |
| Non-Operating Income | $-17.65MM | $5.22MM | $-8.53MM |
| Interest Expense | $7.92MM | $16.10MM | $33.10MM |
| Income(Loss) | $86.62MM | $89.84MM | $80.82MM |
| Taxes | $40.88MM | $31.99MM | $30.89MM |
| Profit(Loss)* | $45.17MM | $60.72MM | $43.15MM |
| Stockholders Equity | $542.56MM | $614.22MM | $712.72MM |
| Assets | $966.21MM | $933.36MM | $1,354.89MM |
| Operating Cash Flow | $82.13MM | $68.23MM | $52.20MM |
| Capital expenditure | $22.94MM | $28.53MM | $8.03MM |
| Investing Cash Flow | $-7.11MM | $-65.52MM | $-192.40MM |
| Financing Cash Flow | $-20.09MM | $3.42MM | $135.15MM |
| Earnings Per Share** | $1.00 | $1.30 | $0.90 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.